Global Lung Cancer Therapeutics market to grow at a CAGR of 3.83 percent over the period 2014-2019

1
Global Lung Cancer Therapeutics Market 2015-2019
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast
Published Date Nov 2014
2
Report Description
About Lung Cancer Cancer occurs when, after
undergoing cell transformation, normal cells grow
and multiply without control. Lung cancer is a
common cause of mortality and morbidity in both
developed and developing countries. Non-small
cell lung cancer is the commonest type of lung
cancer and forms almost 85-90 percent of the
total cases diagnosed. It grows and spreads
slowly. Smoking is considered as a major cause of
lung cancer, though lung cancer also occurs in
non-smokers. Non-small cell lung cancer is of
three types squamous cell (epidermoid)
carcinoma, adenocarcinoma, and large cell
(undifferentiated) carcinoma. Small cell lung
cancers form roughly 10-15 percent of all the
diagnosed cases of lung cancer. There are two
types of small cell lung cancer small cell
carcinoma and combined small cell carcinoma. It
can be classified into two stages limited-stage
small cell lung cancer and extensive-stage small
cell lung cancer. Small cell lung cancer cannot
be cured using current therapies available in the
market. Some of the common symptoms associated
with lung cancer are chest pain, persistent
cough, blood in sputum, fatigue, loss of
appetite, weight loss, shortness of breath, and
wheezing. Both small cell lung cancer and
non-small cell lung cancer are recurrent in
nature, which are difficult to cure. Get
Complete Report At http//www.bigmarketresearch.c
om/global-lung-cancer-therapeutics-2015-2019-marke
t
3
Report Description
The Global Lung Cancer Therapeutics market to
grow at a CAGR of 3.83 percent over the period
2014-2019. Covered in this Report This report
covers the present scenario and the growth
prospects of the Global Lung Cancer Therapeutics
market for the period 2015-2019. To calculate the
market size, the report considers revenue
generated from sales of various drugs used in the
treatment of non-small cell lung cancer and small
cell lung cancer. The Global Lung Cancer
Therapeutics market is segmented based on the
type of molecule used for the treatment of lung
cancer, which include Biologics Small
molecules In addition, the market is also
segmented based on the route of administration
followed for the treatment of lung cancer, which
include Oral Parenteral Enquire About this
report At http//www.bigmarketresearch.com/report
-enquiry/169894
4
Report Description
Global Lung Cancer Therapeutics Market 2015-2019,
has been prepared based on an in-depth market
analysis with inputs from industry experts. The
report covers the Americas, and the EMEA and APAC
regions it also covers the Global Lung Cancer
Therapeutics market landscape and its growth
prospects in the coming years. The report also
includes a discussion of the key vendors
operating in this market. Key Regions Americas
APAC EMEA Key Vendors
AstraZeneca Celgene Eli Lilly F.
Hoffmann-La Roche Pfizer
5
Report Description
Other Prominent Vendors Abbvie Aetna
Agennix Amgen Boehringer Ingelheim
Celldex Eisai GlaxoSmithKline GTx
Helsinn IMClone Merck Serono Novartis
Qiagen OncoGenex OSI Pharmaceuticals
Peregrine Pierre Fabre
6
Report Description
Market Driver High Unmet Need For a full,
detailed list, view our report Market
Challenge High Cost of Therapy For a full,
detailed list, view our report Market Trend
Personalized Medicine For a full, detailed
list, view our report Key Questions Answered in
this Report What will the market size be in
2018 and what will the growth rate be? What are
the key market trends? What is driving this
market? What are the challenges to market
growth? Who are the key vendors in this market
space? What are the market opportunities and
threats faced by the key vendors? What are the
strengths and weaknesses of the key vendors?
7
Table Of Contents
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Product
Profiles 05. Market Research Methodology 06.
Introduction 07. Disease Overview 08. Market
Landscape 09. Market Segmentation by Disease
Type 10. Market Segmentation by Molecule Type 11.
Market Segmentation by Route of
Administration 12. Geographical Segmentation 13.
Buying Criteria 14. Market Growth Drivers 15.
Drivers and their Impact 16. Market
Challenges 17. Impact of Drivers and
Challenges 18. Market Trends 19. Trends and their
Impact 20. Vendor Landscape
8
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/global-lung-cance
r-therapeutics-2015-2019-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
help_at_bigmarketresearch.com